1
|
Pottegård A, Haastrup MB, Stage TB, Hansen MR, Larsen KS, Meegaard PM, Meegaard LHV, Horneberg H, Gils C, Dideriksen D, Aagaard L, Almarsdottir AB, Hallas J, Damkier P. SearCh for humourIstic and Extravagant acroNyms and Thoroughly Inappropriate names For Important Clinical trials (SCIENTIFIC): qualitative and quantitative systematic study. BMJ 2014; 349:g7092. [PMID: 25516539 PMCID: PMC4267482 DOI: 10.1136/bmj.g7092] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVES To describe the development of acronym use across five major medical specialties and to evaluate the technical and aesthetic quality of the acronyms. DESIGN Acronyms obtained through a literature search of Pubmed.gov followed by a standardised assessment of acronym quality (BEAUTY and CHEATING criteria). PARTICIPANTS Randomised controlled trials within psychiatry, rheumatology, pulmonary medicine, endocrinology, and cardiology published between 2000 and 2012. MAIN OUTCOME MEASURES Prevalence proportion of acronyms and composite quality score for acronyms over time. RESULTS 14,965 publications were identified, of which 18.3% (n=2737) contained an acronym in the title. Acronym use was more common among cardiological studies than among the other four medical specialties (40% v 8-15% in 2012, P<0.001). Except for within cardiology, the prevalence of acronyms increased over time, with the average prevalence proportion among the remaining four specialties increasing from 4.0% to 12.4% from 2000 to 2012 (P<0.001). The median combined acronym quality score decreased significantly over the study period (P<0.001), from a median 9.25 in 2000 to 5.50 in 2012. CONCLUSION From 2000 to 2012 the prevalence of acronyms in trial reports increased, coinciding with a substantial decrease in the technical and aesthetic quality of the acronyms. Strict enforcement of current guidelines on acronym construction by journal editors is necessary to ensure the proper use of acronyms in the future.
Collapse
Affiliation(s)
- Anton Pottegård
- Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, DK-5000 Odense C, Denmark
| | - Maija Bruun Haastrup
- Department of Clinical Chemistry and Pharmacology, Odense University Hospital, Odense C, Denmark
| | - Tore Bjerregaard Stage
- Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, DK-5000 Odense C, Denmark
| | - Morten Rix Hansen
- Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, DK-5000 Odense C, Denmark
| | - Kasper Søltoft Larsen
- Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, DK-5000 Odense C, Denmark
| | - Peter Martin Meegaard
- Capital Region Pharmacy, Clinical pharmaceutical Services, Rigshospitalet, Copenhagen, Denmark
| | | | - Henrik Horneberg
- Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, DK-5000 Odense C, Denmark
| | - Charlotte Gils
- Department of Clinical Chemistry and Pharmacology, Odense University Hospital, Odense C, Denmark
| | - Dorthe Dideriksen
- Department of Clinical Chemistry and Pharmacology, Odense University Hospital, Odense C, Denmark
| | - Lise Aagaard
- Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, DK-5000 Odense C, Denmark
| | - Anna Birna Almarsdottir
- Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, DK-5000 Odense C, Denmark Department of Clinical Chemistry and Pharmacology, Odense University Hospital, Odense C, Denmark
| | - Jesper Hallas
- Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, DK-5000 Odense C, Denmark Department of Clinical Chemistry and Pharmacology, Odense University Hospital, Odense C, Denmark
| | - Per Damkier
- Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, DK-5000 Odense C, Denmark Department of Clinical Chemistry and Pharmacology, Odense University Hospital, Odense C, Denmark
| |
Collapse
|
2
|
Cheng TO. Do we need to be an Einstein to figure out what the acronym in the EINSTEIN study stands for? Int J Cardiol 2011; 149:145-146. [DOI: 10.1016/j.ijcard.2011.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/06/2011] [Accepted: 02/06/2011] [Indexed: 10/18/2022]
|